주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요 새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Global Press Office

방대하고 지속적으로 업데이트되는 글로벌 학술, 연구 및 의료 커뮤니티를 선도하는 타이틀, 연구 결과 및 기술 포트폴리오 관련 소식

연락처(새 탭/창에서 열기)
Rear view of large group of people raising their arms to ask questions at press conference

새로운 소식 및 경험 공유

엘스비어는 사회적 이익을 위한 연구자와 의료 전문가들의 과학의 증진과 의료 결과 개선을 향한 노력을 지원하고 있으며 140년 넘게 글로벌 의료 및 연구 커뮤니티의 손꼽히는 지원자이자 동반자로서 걸어가고 있습니다.

Elsevier is a global leader in advanced information and decision support for science and healthcare. For more than 140 years, we’ve helped advance science and healthcare to advance human progress, and that same mission drives us today. We are part of RELX 새 탭/창에서 열기, a FTSE 10 company and global provider of information-based analytics and decision tools for professional and business customers.

The communities we serve across academia, R&D driven industries and healthcare are working to solve some of the world’s biggest challenges -- we strive to bring them the best solutions and to be the best partner possible for progress. We deliver insights that help research institutions, governments and funders achieve their goals. We help researchers discover and share knowledge, collaborate, and accelerate innovation. We help librarians provide verified, quality information to universities. We help innovators turn knowledge into new medicines and products. We help health professionals improve patient care and educators train the next generation of doctors and nurses.

Our trusted brands include the world’s leading research platforms like ScienceDirect and Scopus, technical databases such as Reaxys for chemicals, best-in-class clinical tools like ClinicalKey and innovative learning platforms such as Sherpath and Osmosis for nursing — all enriched by responsible AI.

Last year, our 3,000+ scientific journals received 3.5 million research papers and published 720K articles after rigorous editorial and peer review, reflecting our focus on quality. This is also reflected in the fact that the research published by Elsevier accounts for 17% of global research articles and 29% of global citations.